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Résumé en
anglais
Extracellular vesicles (EVs)-particularly exosomes and microvesicles (MVs)-are
attracting considerable interest in the cardiovascular field as the wide range of their
functions is recognized. These capabilities include transporting regulatory molecules
including different RNA species, lipids, and proteins through the extracellular space
including blood and delivering these cargos to recipient cells to modify cellular
activity. EVs powerfully stimulate angiogenesis, and can protect the heart against
myocardial infarction. They also appear to mediate some of the paracrine effects of
cells, and have therefore been proposed as a potential alternative to cell-based
regenerative therapies. Moreover, EVs of different sources may be useful biomarkers
of cardiovascular disease identities. However, the methods used for the detection and
isolation of EVs have several limitations and vary widely between studies, leading to
uncertainties regarding the exact population of EVs studied and how to interpret the
data. The number of publications in the exosome and MV field has been increasing
exponentially in recent years and, therefore, in this ESC Working Group Position
Paper, the overall objective is to provide a set of recommendations for the analysis
and translational application of EVs focussing on the diagnosis and therapy of the
ischaemic heart. This should help to ensure that the data from emerging studies are
robust and repeatable, and optimize the pathway towards the diagnostic and
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